Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
News headline image
Robbins LLP Urges CAPR Stockholders Who Lost Money Investing in Capricor Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
Via Newsfile
Topics Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
News headline image
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates ↗
Via Benzinga
Exposures Product Safety
News headline image
GeoVax Highlights Gedeptin(R) Tumor-Priming Strategy as Immuno-Oncology Enters New Phase
Via NewMediaWire
Tickers GOVX
Exposures Product Safety
News headline image
Taylor Farms Recalls Jalapeño Products Amid Salmonella Outbreak— Chuck Schumer Says Trump Is Doing Everything to ‘Make America Sick Again’ ↗
Via Benzinga
Topics Government Product Recall
Exposures Legal Political Product Safety
News headline image
Timothy Bradbury Monzello Calls for Stronger Manufacturing Education and Practical Engineering Skills
Via 24-7 Press Release
Topics Product Recall
Exposures Legal Product Safety
News headline image
Constar Reaches 15 Million Monthly Lens Production Capacity Across Six China Facilities
Via AB Newswire
Topics Economy
Exposures Product Safety Supply Chain
News headline image
PRISM Medical Care Positions Nevada Patients for Safe, Clinically Supervised GLP-1 Therapy as Federal Scrutiny of Prescription Mills Intensifies
Via AB Newswire
Exposures Product Safety
News headline image
Best VELO Nicotine Pouches in 2026: Buyer's Guide | USA NICO ↗
Via Talk Markets
Exposures Product Safety
News headline image
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial ↗
Via MarketBeat
Tickers SLN
Exposures Product Safety
News headline image
Oncocyte Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers IMDX
Exposures Financial Product Safety
News headline image
Fractyl Health Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers GUTS
Exposures Financial Product Safety
News headline image
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study ↗
Via Benzinga
Exposures Product Safety
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
News headline image
FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detection Test ↗
Via Benzinga
Exposures Product Safety
News headline image
Nicolet Law Files First Lawsuit in the Nation Over Salmonella Javiana Outbreak Linked to Contaminated Jalapeños
Via Law Firm Newswire
Topics Economy Lawsuit Product Recall
Exposures Financial Legal Product Safety
News headline image
Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule ↗
Via Benzinga
Exposures Product Safety
News headline image
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles ↗
Via MarketBeat
Tickers NRXP
Exposures Product Safety
News headline image
Ulcerative Colitis Market: Size, Trends, and Strategic Outlook 2026-2033 ↗
Via Talk Markets
Topics Economy
Exposures Product Safety Supply Chain
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
News headline image
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
Via Newsfile
Topics Intellectual Property
Tickers ASX:COH COCH
Exposures Intellectual Property Product Safety
News headline image
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
Via Benzinga
Exposures Product Safety
News headline image
EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Trial ↗
Via Benzinga
Exposures Product Safety
News headline image
Future Outlook of the Ovarian Cancer Drugs Market: Size, Trends & Growth ↗
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Global Precision Medicine Market: Size, Trends, Drivers, and Forecast 2026-2033 ↗
Via Talk Markets
Topics Artificial Intelligence
Tickers PFE
Exposures Artificial Intelligence Product Safety
News headline image
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision? ↗
Via The Motley Fool
Tickers KDP PM TPB
Exposures Product Safety
News headline image
MDLN Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.